Injectable Biomaterial Turns Stroke Cavities Into Repair Hubs, Restoring Motor Function in Mice
Key Insights
Duke University (search) researchers developed an injectable microporous scaffold that transforms stroke-damaged brain cavities into sites of coordinated tissue repair in mouse models.
The biomaterial, combined with astrocyte-derived extracellular vesicles, recruited immune cells including neutrophils that unexpectedly promoted blood vessel formation and tissue remodeling.
Treated mice regained motor function approaching healthy controls by eight weeks, with performance statistically indistinguishable from healthy animals in grid-walking tests.
Duke University (search) biomedical engineers have demonstrated that an injectable biomaterial can turn the fluid-filled cavities left by severe strokes into hubs of repair, restoring near-normal motor function in mice by recruiting the body's own immune cells to rebuild blood vessels and nerve fibers. The findings, published July 21, 2026 in Cell Biomaterials, represent a potential paradigm shift in how clinicians approach brain repair after ischemic stroke (search).
"Once brain tissue has been lost, restoring blood flow is no longer enough," said Tatiana Segura, the Robert Plonsey Distinguished Professor of Biomedical Engineering at Duke. "Our goal is to engineer the injured space so that immune, vascular, and neural repair processes can begin to work together."
An Engineered Scaffold, Not a Brain Replacement
The treatment is built on microporous annealed particle scaffolds, or MAPS — an injectable material assembled from tiny hydrogel particles that connect after delivery while leaving open spaces between them. Unlike a solid gel, the porous structure gives cells room to enter, move, and form new tissue without waiting for the entire material to degrade first.
Rather than attempting to manufacture replacement brain tissue, Segura's team designed the scaffold as a temporary framework that encourages the body to do more of the rebuilding itself. The material was injected directly into the stroke cavity five days after injury, positioning it as a repair strategy rather than an emergency intervention.
Astrocyte-Derived Signals Shape the Immune Response
The key innovation involved attaching extracellular vesicles (EVs) — nanoscale packages of proteins, lipids, and genetic material — harvested from astrocytes to the hydrogel particles. Astrocytes are star-shaped support cells that react rapidly to brain injury and communicate partly through these vesicles.
Researchers grew astrocytes in the laboratory and exposed them to different signaling molecules, then collected the EVs produced under those conditions. EVs generated after astrocytes were exposed to IL-4 (search) and C1q (search) produced the strongest results, attracting macrophages and a surprisingly persistent population of neutrophils into the stroke cavity.
By chemically tethering the vesicles to the scaffold, the team transformed the material into a localized signaling hub. "We are not simply placing a material into the brain," Segura said. "We are engineering a local environment that can coordinate several parts of the repair response."
Neutrophils: From Destructive to Constructive
Neutrophils are typically associated with inflammation and additional tissue damage in the early phase of stroke. Yet inside the engineered scaffold, these immune cells appeared to become part of the repair process.
When researchers depleted the immune-cell population rich in neutrophils, blood vessel formation dropped sharply and the scaffold underwent far less remodeling — demonstrating that these cells were actively driving the repair response.
"This result changes how we think about neutrophils after stroke," said Shangjing Xin, lead scientist of the study and a postdoctoral fellow in the Segura Laboratory. "Their role appears to depend on when they arrive, where they are located, and the signals they receive from their surroundings. Our study demonstrates a potential engineering strategy to recruit and retain these cells at the right time."
Restoring Blood Vessels, Nerve Fibers, and Motor Function
The treatment produced measurable biological changes: blood vessels grew across the cavity, potentially creating the circulation needed to support living tissue, and researchers detected more axonal fibers within and around the injury.
These changes translated into functional recovery. In a grid-walking test measuring how often mice misplaced a front paw on an uneven surface, animals treated with the optimized scaffold made progressively fewer errors. By eight weeks, their performance could not be statistically distinguished from that of healthy control mice, and improvement continued through the end of the study.
The scaffold proved essential to the outcome. When researchers delivered the EVs without MAPS, they did not observe comparable blood vessel growth, confirming that the treatment depended on both the biological messages carried by the vesicles and the porous structure that concentrated those signals.
Toward Clinical Translation
The study relied on EVs collected from primary rat astrocytes, which would not be a practical source for a widely available human therapy. Segura's laboratory is now exploring astrocytes made from human-induced pluripotent stem cells — reprogrammed adult cells that can be expanded in the laboratory — as a potentially more scalable and clinically relevant source of EVs.
"You do not restore an ecosystem simply by containing the initial damage," Segura said. "You have to create the conditions that allow life to return. That is how we think about the stroke cavity. The material is not intended to reproduce the brain itself but to create an environment where the body's own cells can enter, communicate, and participate in rebuilding vascularized tissue."
The researchers note that the findings are preliminary and additional studies are needed to evaluate safety, determine how different immune-cell populations contribute to recovery, and test the approach in larger and more clinically representative stroke models.